Page last updated: 2024-09-04

kw 2189 and duocarmycin b2

kw 2189 has been researched along with duocarmycin b2 in 1 studies

Compound Research Comparison

Studies (kw 2189)	Trials (kw 2189)	Recent Studies (post-2010) (kw 2189)	Studies (duocarmycin b2)	Trials (duocarmycin b2)	Recent Studies (post-2010) (duocarmycin b2)
10	4	0	13	0	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asada, M; Asai, A; Gomi, K; Hirata, T; Kobayashi, E; Nagamura, S; Okabe, M; Okamoto, A; Saito, H	1

Other Studies

1 other study(ies) available for kw 2189 and duocarmycin b2

Article	Year
Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors. Cancer research, 1994, May-01, Volume: 54, Issue:9 Topics: Animals; Antibiotics, Antineoplastic; DNA Damage; DNA, Neoplasm; Drug Screening Assays, Antitumor; Duocarmycins; HeLa Cells; Humans; Indoles; Lethal Dose 50; Male; Mice; Mice, Nude; Pyrrolidinones; Sarcoma 180; Tumor Cells, Cultured	1994

Article

Year

Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.

Cancer research, 1994, May-01, Volume: 54, Issue:9

Topics: Animals; Antibiotics, Antineoplastic; DNA Damage; DNA, Neoplasm; Drug Screening Assays, Antitumor; Duocarmycins; HeLa Cells; Humans; Indoles; Lethal Dose 50; Male; Mice; Mice, Nude; Pyrrolidinones; Sarcoma 180; Tumor Cells, Cultured

1994